While Illinois, New Jersey and New York are bearing the brunt of the outbreak, with 156, 106 and 319 cases respectively, nine other states have also reported cases. Additionally, 1,123 patients were found to be colonized with C. auris but not showing symptoms.
The number of U.S.-based cases of the infection has jumped by 26 this month alone. In an April 10 update, the CDC reported 587 cases of C. auris in the country.
C. auris cases have been reported globally, including multiple cases in Australia, Canada, China, Colombia, France, Germany and India.
C. auris is difficult to treat because it is often multidrug-resistant. It has caused bloodstream infections, wound infections and ear infections.
More articles on healthcare quality:
Physician visits crucial for patients at skilled nursing facilities, study finds
Arizona grants license to facility where patient in vegetative state gave birth
2 HIV cases linked to ‘vampire facials’ at New Mexico spa
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
